Fact CheckerSign in

NCT06706609Not yet recruiting

Classification of Adult-onset Diabetes in Five Subgroups in Pakistani Population

Source: ClinicalTrials.gov · Last updated 26 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to classify adult-onset diabetes patients into distinct data-driven clusters, such as severe insulin-deficient, severe insulin-resistant, mild obesity-related, and mild age-related diabetes, based on clinical and biochemical characteristics. Using a cross-sectional design, data will be collected from individuals attending outpatient diabetes clinics at tertiary care hospitals in Pakistan. The study will analyze the distribution of metabolic and demographic characteristics within each cluster and assess subgroup-specific risks for diabetic complications. Additionally, the relationship between clustering variables and the risk of complications will be evaluated to enhance the understanding of diabetes heterogeneity and its impact on patient outcomes.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
394 (estimated)
First submitted
22 Nov 2024
Start date
1 Feb 2025
Primary completion date
1 Aug 2025
Lead sponsor
Getz Pharma
NCT number
NCT06706609

What you commit to

  • Study type: Observational
  • Planned participants: 394
  • From 1 Feb 2025 to the primary completion date, 1 Aug 2025
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with other medical comorbidities (not a complication of diabetes), such as malignancies.

Other

  • Pregnancy

Who the study is looking for

  • Patients of both genders whose age of disease onset was older than 16 years
  • Patients newly diagnosed with or previously diagnosed with T2D
  • Able and willing to provide written informed consent and to comply with the study

Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.